Science Supported Research
Rosa's industry-proven, scientifically rigorous ForecastMD Platforms are the best way to prove the commercial value of your diagnostic tests. The models can assure investors that your diagnostic test's potential ROI is real and that your terms and evaluations are fair.
Download: The Science Behind the ModelRosa ForcastMD Platforms
Why Rosa & Co.?
20 Years Experience
For 20 years, Rosa has delivered insights that are difficult, if not impossible, to achieve in any other way.
Scientific Rigor
Using advanced applied mathematics-based tools, Rosa’s models consider complex interactions on how all factors interact with a wide variety of current and future competitive scenarios.
Credible & Neutral
Our ForecastMD Platforms are transparent and cover a wide range of factors, including product performance on key features such as test accuracy, related test logistics, pricing/insurance coverage, and recommendations by thought leaders.
Providing solid and credible evidence, Rosa’s ForecastMD Platforms are the antidote to traditional, unrealistic, overly optimistic revenue forecasts.
Download: The Science Behind the ModelRosa Market Modeling
On-Demand Webinar
Strategies for Successful Commercialization
Market modeling pioneers and long-time executive-level customers explain how Rosa's breakthrough market modeling methodology has guided their strategies to commercialize their products.
Ron Beaver, PhD
Founder, Chairman, and CEO
Dr. Beaver founded Rosa in 2002 and has 25 years of experience in the biotechnology, pharmaceutical, diagnostics, and consumer health industries. Under Dr. Beaver’s leadership, Rosa teams create Market Models to guide client decisions such as the positioning of novel diagnostic tests and the implementation of innovative pricing models. Rosa teams also develop PhysioPD™ Research Platforms that clarify connections between disease mechanisms, therapeutic interventions, and clinical outcome.
William C. Brastow, PhD
Principal and Chief Technology Officer, Market Modeling
As the Chief Technology Officer of Rosa’s Market Modeling practice, Dr. Brastow leads Rosa’s Market Modeling practice, in which he specializes in the design and implementation of customized market research surveys, physician choice models, and dynamic market models for biopharmaceutical and diagnostic companies.
Robert W. Singer
Principal, Rosa Market Modeling
Rob Singer brings over 20 years of experience in the healthcare market research field to Rosa & Co. Prior to joining Rosa, Rob conducted market research projects for Biotech, Pharmaceutical, Medical Device and Diagnostic Companies with Promedica and Cello Health Insight. During that time, Rob had the opportunity to partner with Bill Brastow on numerous Rosa Market Modeling projects.
Email RobertRosa Market Modeling enables cross-functional and board-level agreement about product design and promotional messaging.
- Ted Snelgrove, Chief Business Officer, Lexent Bio